Pulmonary Hypertension Trial, Recruiting NCT07311044 Sponsor: Mayo Clinic Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07311044
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People attending Mayo Clinic's echocardiography laboratory for a routine, planned heart ultrasound that has been ordered for medical reasons.
  • People who have already had a medically ordered heart ultrasound at Mayo Clinic's echocardiography laboratory before a planned procedure in the cardiac catheterization lab at Mayo Clinic.
  • People who have had a medically ordered heart ultrasound at Mayo Clinic's echocardiography laboratory and also have an upcoming appointment at any heart and blood vessel (cardiovascular) outpatient clinic.

Who may not be able to join:

  • People who have a known history of a voice disorder, whether caused directly by a voice condition or as a result of a nerve, muscle, or other health problem.
  • People under the age of 18 years.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amir Lerman, M.D., Mayo Clinic

Phone: 507-255-6884

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
8 January 2021
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of confirmed pulmonary hypertension diagnoses based on voice recording analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov